Monday, May 16, 2022
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | World | Uk Launches 3rd Booster Dose Trial Of 7 Covid Vax

UK launches 3rd booster dose trial of 7 Covid vax

By IANS
Published: Published Date - 04:36 PM, Fri - 21 May 21
Photo: IANS The trial will assess Covid-19 vaccines of Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, Novavax, Valneva, Janssen and Curevac.

London: In a first, the UK has launched a new clinical trial that will assess the efficacy of a third ‘booster’ dose of seven different Covid-19 vaccines on patients’ immune responses, the media reported.

The trial will assess Covid-19 vaccines of Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, Novavax, Valneva, Janssen and Curevac.

The trial, named Cov-Boost, aims to begin in June and recruit 3,000 people of all ages who had their first dose in December or January, to test if this is worthwhile, the BBC reported on Thursday.

It costs 19.3 million pound and is being funded by the UK government and led by the University Hospital Southampton NHS Foundation Trust, the report said.

“It could be that some age groups may not need a booster and others do,” Professor Saul Faust, chief investigator for the trial, from the University of Southampton, was quoted as saying.

“We are not trying to say one is better than the other.

“The aim is to find out whether there should be a booster campaign and which vaccine to use,” he said.

Prof Faust said he was not expecting any vaccines to be “detrimental” but some could cause high fevers or very sore arms, for example, which would be useful to know.

The vaccines will be trialled at 18 sites across the UK, and half doses will also be tested.

Besides data on side-effects and immune responses, the findings will also help vaccine advisers decide if re-vaccinating some people in the autumn is necessary, the report said.

The participants will be asked to keep diaries of any side-effects after a third dose, and their immune responses will be tested after one, three and 12 months.

This involves testing their blood for antibodies to Coronavirus — high levels are a sign that the body’s defences are primed to fight off the virus.

There will also be a control group, who will be given a dummy vaccine. The researchers aim to release the initial trial data in in September.

  • Follow Us :
  • Tags
  • Clinical Trial
  • Covid-19
  • immune responses
  • London

Related News

  • India records 2,202 new COVID-19 infections, 27 fatalities

  • JNTU-Hyderabad to revamp curriculum of all its courses

  • Banks need a new playbook

  • India records 2,858 COVID-19 cases, 11 fatalities

  • New Zealand PM Jacinda Ardern tests positive for COVID-19

  • Half of Covid patients show one symptom even 2 years after infection: Lancet

Latest News

  • The dying art of handwritten letters

    4 mins ago
  • Why you should ditch shampoo and co-wash your hair instead

    19 mins ago
  • Kenyan athletes smash into record books at World 10K Bengaluru 2022

    34 mins ago
  • First look poster, title unveiled for Vijay Deverakonda-Samantha film

    36 mins ago
  • If you don’t like our content, you can quit: Netflix to workers

    48 mins ago
  • Bayern preparing for Lewandowski’s departure

    1 hour ago
  • Ex-Andhra minister Narayana’s daughters, son-in-law get anticipatory bail

    1 hour ago
  • Sensex jumps nearly 274 points in early trade; Nifty climbs to 15,873

    2 hours ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam